PDL BioPharma Inc. (PDLI)

[Lil' Jon]

Oct. 8th, 2012; Eli Lilly made this important announcement on the Alzheimer medication Solanezumab, of which, if successful, PDL BioPharma will receive royalties from.

Mr. Funtleyder makes that assertion near the end of this video on Bloomberg.

http://us.rd.yahoo.com/finance/external/bloomberg/SIG=1335p4e22/*http://www.bloomberg.com/video/funtleyder-on-lilly-s-alzheimer-s-drug-nWW6TV~eTdmCZYnGfrGxjg.html?cmpid=yhoo
__________________________________________________________

"An experimental Alzheimer's treatment from Eli Lilly & Co. slowed memory loss by 42% in patients with a mild form of the memory-robbing disease in one drug trial and showed positive signs of doing so in another study, according to new data presented on Monday.

The results, although mixed, bolster hopes that a drug like Lilly's solanezumab could stymie Alzheimer's destructive march in patients in the early stage of the disease. Current therapies do nothing more than treat the symptoms. Yet more studies probably will be needed to reach a firm conclusion.

"Our next step is to talk to the regulators to see what this means, although we think this is a step forward in getting to a treatment for Alzheimer's," David Ricks, president of Lilly Bio-Medicines, said in an interview.

http://online.wsj.com/article/SB10000872396390444897304578044520966644406.html